Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2008-2-12
pubmed:abstractText
Advanced stage/metastatic soft tissue sarcoma (STS) has a poor prognosis especially after failure of the established first-line treatment. In patients with relapsed leiomyosarcoma, however, the combination of gemcitabine (G) and docetaxel (D) recently has emerged as a valuable salvage therapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1423-0240
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11-6
pubmed:meshHeading
pubmed-meshheading:18268394-Adult, pubmed-meshheading:18268394-Aged, pubmed-meshheading:18268394-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18268394-Deoxycytidine, pubmed-meshheading:18268394-Disease Progression, pubmed-meshheading:18268394-Dose-Response Relationship, Drug, pubmed-meshheading:18268394-Drug Administration Schedule, pubmed-meshheading:18268394-Female, pubmed-meshheading:18268394-Humans, pubmed-meshheading:18268394-Leiomyosarcoma, pubmed-meshheading:18268394-Male, pubmed-meshheading:18268394-Middle Aged, pubmed-meshheading:18268394-Neoplasm Staging, pubmed-meshheading:18268394-Palliative Care, pubmed-meshheading:18268394-Retrospective Studies, pubmed-meshheading:18268394-Sarcoma, pubmed-meshheading:18268394-Survival Analysis, pubmed-meshheading:18268394-Taxoids, pubmed-meshheading:18268394-Uterine Neoplasms
pubmed:year
2008
pubmed:articleTitle
Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience.
pubmed:affiliation
Innere Klinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, Germany. peter.ebeling@uni-due.de
pubmed:publicationType
Journal Article